サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1515603

がん性悪液質市場：療法別、作用機序別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Cancer Cachexia Market, By Therapeutics, By Mechanism of Action, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
がん性悪液質市場：療法別、作用機序別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

がん性悪液質の市場規模は2023年に32億2,832万米ドルと評価され、2024年から2032年にかけてCAGR 5.90%で拡大

がん性悪液質市場-市場力学

がん負担の増加が市場需要を促進

世界のがん負担の増加により、国や地域の優先順位に応じたがん治療の変更が必要となっています。2020年12月の国際がん研究機関（IARC）によると、世界の5人に1人が一生の間にがんに罹患し、女性の11人に1人、男性の8人に1人ががんで死亡するといいます。2022年2月に発表されたWHOのデータによると、年間約40万人の子どもががんに罹患しており、最も多いタイプは国によって異なります。例えば、子宮頸がんは23カ国で最も多いです。世界のがん罹患率の増加は、がん性悪液質の有病率も高めています。この悪液質は、タンパク質とエネルギーの負のバランス、全身性の炎症、除脂肪体重の不随意的な減少を特徴とします。がん性悪液質およびがんの有病率の増加は、新規がん性悪液質治療のための研究開発投資の増加とともに、市場成長を促進する主な要因となっています。

がん性悪液質市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約5.90%のCAGRで毎年成長すると予測されています。

療法のセグメンテーションに基づくと、2023年にはプロゲストーゲンが最大の市場シェアを示すと予測されます。

作用機序のセグメンテーションに基づくと、2023年には食欲刺激剤が主要タイプに

地域別では、北米が2023年に収益でリードしました。

がん性悪液質市場-セグメンテーション分析：

世界のがん性悪液質市場は、治療薬、作用機序、用途、地域に基づいて大きく区分されます。

市場は治療薬に基づき、黄体ホルモン、副腎皮質ホルモン、併用療法、その他の4つのカテゴリーに分けられます。プロゲストーゲン・セグメントは、がん性悪液質の治療において低コストかつ高効率であることから、2023年には圧倒的な市場シェアを占めました。

市場は作用機序によって2つのカテゴリーに大別される：食欲刺激剤と体重減少安定剤です。作用機序別では、食欲刺激剤ががん性悪液質市場を独占し、大きく成長すると予想されます。がん患者はしばしば食欲不振や意図しない体重減少を経験するが、これらはパフォーマンスステータスの低下、治療に対する反応や耐性の低下、生存率の低下、QOLの低下につながります。そのため、食欲が低下している患者に対して食欲増進剤の使用が検討されるようになってきています。がん性悪液質の有病率の上昇は、市場の成長を促進する主な要因です。

がん性悪液質市場-地理的洞察

地理的な観点から、この市場は欧州、北米、ラテンアメリカ、アジア太平洋、中東・アフリカに広がっています。これらの地域は参加国に基づいてさらに区分されます。北米は、がんおよびがん性悪液質の負担が大きいこと、多数の医薬品メーカーが存在すること、がん患者の治療が進歩していることなどが要因となって、市場をリードすると予想されます。GLOBOCAN 2020の推計によると、メキシコでは約195,499人の新規がん患者が報告されています。また、米国がん協会は、2022年に米国で約190万人のがん患者が新たに診断されると予測しています。

がん性悪液質市場-競合情勢：

がん性悪液質市場は統合されており、世界および地域で事業を展開する主要企業は数社に限られています。これらの主な企業は、主にがん性悪液質を治療するための有効性の高い新薬の研究開発に注力しており、その結果、承認と商業的発売を待つ治療薬のパイプラインが増加しています。2022年10月現在、clinicaltrials.govは、がん性悪液質の治療薬を開発するために実施または進行中の150の研究を報告しています。例えば、2020年12月、コペンハーゲン大学はニュージーランド大学病院と共同で、オキサリプラチンまたはパクリタキセルベースの化学療法を受けている患者の除脂肪体重（悪液質）に対する医療用カンナビジオールの効果をモニターする研究を開始しました。

目次

第1章 がん性悪液質市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 がん性悪液質の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 がん性悪液質産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 がん性悪液質市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 がん性悪液質市場情勢

  • がん性悪液質市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 がん性悪液質市場- 療法別

  • 概要
    • セグメントシェア分析
    • プロゲストーゲン
    • コルチコステロイド
    • 併用療法
    • その他の療法

第8章 がん性悪液質市場- 作用機序別

  • 概要
    • セグメントシェア分析
    • 食欲増進剤
    • 減量安定剤

第9章 がん性悪液質市場- 用途別

  • 概要
    • セグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第10章 がん性悪液質市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- がん性悪液質業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Aeterna Zentaris
    • Aphios Corporation
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Helsinn Group
    • Merck KGaA
    • Artelo Biosciences Inc.
    • NGM Biopharmaceuticals
    • Aveo Oncology
    • Aavogen Inc.
    • Green Cross Wellbeing Corporation
    • Cannabics Pharmaceuticals Inc.
    • TCI Peptide Therapeutics
    • Fresenius Kabi
    • Tetra Bio-Pharma
    • Actimed Therapeutics
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Cachexia Market: Therapeutics Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutics
  • TABLE Global Cancer Cachexia Market, by Therapeutics 2019-2032 (USD Million)
  • TABLE Cancer Cachexia Market: Mechanism of Action Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mechanism of Action
  • TABLE Global Cancer Cachexia Market, by Mechanism of Action 2019-2032 (USD Million)
  • TABLE Cancer Cachexia Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Cachexia Market, by Application 2019-2032 (USD Million)
  • TABLE Cancer Cachexia Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Cachexia Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE North America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Europe Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Latin America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cancer Cachexia Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Cancer Cachexia Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Therapeutics segment market share analysis, 2023 & 2032
  • FIGURE Therapeutics segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mechanism of Action segment market share analysis, 2023 & 2032
  • FIGURE Mechanism of Action segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Cancer Cachexia Market share and leading players, 2023
  • FIGURE Europe Cancer Cachexia Market share and leading players, 2023
  • FIGURE Asia Pacific Cancer Cachexia Market share and leading players, 2023
  • FIGURE Latin America Cancer Cachexia Market share and leading players, 2023
  • FIGURE Middle East and Africa Cancer Cachexia Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Cancer Cachexia Market share analysis by country, 2023
  • FIGURE Germany Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Cancer Cachexia Market share analysis by country, 2023
  • FIGURE India Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cancer Cachexia Market share analysis by country, 2023
  • FIGURE Brazil Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cancer Cachexia Market share analysis by country, 2023
  • FIGURE Saudi Arabia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3357

REPORT HIGHLIGHT

Cancer Cachexia Market size was valued at USD 3,228.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

Cancer cachexia presents as a multifaceted metabolic syndrome frequently observed in patients with advanced stages of malignancy. Characterized by involuntary weight loss, skeletal muscle wasting, fatigue, and anorexia, this syndrome transcends the limitations of inadequate dietary intake. Underlying mechanisms encompass systemic inflammation, metabolic aberrations, and the host's response to tumor-derived factors. Despite advancements in oncological therapies, cancer cachexia remains a formidable challenge, significantly impacting both the treatment outcomes and quality of life for affected individuals.

Cancer Cachexia Market- Market Dynamics

Rising cancer burden to propel market demand

The global cancer burden is rising, necessitating the modification of cancer therapies according to national and regional priorities. According to the (IARC) International Agency for Research on Cancer in December 2020, 1 in 5 people globally will develop cancer during their lifetime, with 1 in 11 women and 1 in 8 men dying from the disease. Data from the WHO, published in February 2022, indicates that approximately 400,000 children develop cancer annually, with the most common types varying by country. For instance, cervical cancer is the most prevalent in 23 countries. The increasing global cancer burden also raises the prevalence of cancer cachexia, characterized by negative protein and energy balance, systemic inflammation, and involuntary loss of lean body mass. The growing prevalence of cancer cachexia, and cancer along with increased investment in R&D for novel cancer cachexia treatments, are major factors driving market growth.

Cancer Cachexia Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Therapeutics segmentation, progestogens were predicted to show maximum market share in the year 2023

Based on the mechanism of action segmentation, appetite stimulators were the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Cancer Cachexia Market- Segmentation Analysis:

The Global Cancer Cachexia Market is broadly segmented on the basis of Therapeutics, Mechanism of Action, Application, and Region.

The market is divided into four categories based on Therapeutics: progestogens, corticosteroids, combination therapies, and others. The progestogens segment held a dominant market share in 2023, due to their lower cost and high efficiency in treating cancer cachexia.

The market is broadly divided into two categories based on mechanism of action: Appetite Stimulators and Weight Loss Stabilizers. By mechanism of action, appetite stimulators are expected to dominate and grow significantly in the cancer cachexia market. Cancer patients often experience sort of appetite loss and unintended weight loss, which are linked to decreased performance status, reduced response and tolerance to treatment, decreased survival, and diminished quality of life. Therefore, the use of appetite stimulants is increasingly considered for patients with reduced appetite. The rising prevalence of cancer cachexia is a major factor driving the market's growth.

Cancer Cachexia Market- Geographical Insights

From a geographical perspective, this market extends across Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the participating nations. North America is expected to lead the market, driven by the high burden of cancer and cancer cachexia, the presence of numerous drug manufacturers, and advancements in cancer patient care. According to GLOBOCAN 2020 estimates, Mexico reported around 195,499 new cancer cases. Additionally, the American Cancer Society projected approximately 1.9 million new cancer cases would be diagnosed in the United States in 2022.

Cancer Cachexia Market- Competitive Landscape:

The cancer cachexia market is consolidated, with only a few major companies operating globally and regionally. These key players are primarily focused on R&D to develop highly effective novel drugs for treating cancer cachexia, resulting in a growing pipeline of therapeutics awaiting approval and commercial launch. As of October 2022, clinicaltrials.gov reported 150 studies either conducted or ongoing to develop drugs for cancer cachexia. For instance, in December 2020, the University of Copenhagen, in collaboration with Zealand University Hospital, initiated a study to monitor the effect of the medical cannabidiol on the lean body mass (cachexia) in patients receiving Oxaliplatin- or Paclitaxel-based chemotherapy.

Recent Developments:

In January 2021, Helsinn Group and Ono Pharmaceutical Co. Ltd received approval in Japan to manufacture and market Adlumiz, a ghrelin receptor agonist for treating cancer cachexia in the patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Therefore, increasing research and development activities in the field are expected to drive market growth.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER CACHEXIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Aeterna Zentaris

Aphios Corporation

Bristol-Myers Squibb Company

Pfizer Inc.

Helsinn Group

Merck KGaA

Artelo Biosciences Inc.

NGM Biopharmaceuticals

Aveo Oncology

Aavogen Inc.

Green Cross Wellbeing Corporation

Cannabics Pharmaceuticals Inc.

TCI Peptide Therapeutics

Fresenius Kabi

Tetra Bio-Pharma

Actimed Therapeutics

Others

GLOBAL CANCER CACHEXIA MARKET, BY THERAPEUTICS - MARKET ANALYSIS, 2019 - 2032

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Other Therapeutics

GLOBAL CANCER CACHEXIA MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Appetite Stimulators
  • Weight Loss Stabilizers

GLOBAL CANCER CACHEXIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

GLOBAL CANCER CACHEXIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Cachexia Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Cachexia Market Snippet by Therapeutics
    • 2.1.2. Cancer Cachexia Market Snippet by Mechanism of Action
    • 2.1.3. Cancer Cachexia Market Snippet by Application
    • 2.1.4. Cancer Cachexia Market Snippet by Country
    • 2.1.5. Cancer Cachexia Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Cachexia Key Market Trends

  • 3.1. Cancer Cachexia Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Cachexia Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Cachexia Market Opportunities
  • 3.4. Cancer Cachexia Market Future Trends

4. Cancer Cachexia Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Cachexia Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Cachexia Market Landscape

  • 6.1. Cancer Cachexia Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Cachexia Market - By Therapeutics

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapeutics, 2023 & 2032 (%)
    • 7.1.2. Progestogens
    • 7.1.3. Corticosteroids
    • 7.1.4. Combination Therapy
    • 7.1.5. Other Therapeutics

8. Cancer Cachexia Market - By Mechanism of Action

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
    • 8.1.2. Appetite Stimulators
    • 8.1.3. Weight Loss Stabilizers

9. Cancer Cachexia Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy
    • 9.1.4. Online Pharmacy

10. Cancer Cachexia Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Cachexia Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Cachexia Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Cachexia Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Cachexia Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Cachexia Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Cachexia Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Aeterna Zentaris
    • 11.2.2. Aphios Corporation
    • 11.2.3. Bristol-Myers Squibb Company
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Helsinn Group
    • 11.2.6. Merck KGaA
    • 11.2.7. Artelo Biosciences Inc.
    • 11.2.8. NGM Biopharmaceuticals
    • 11.2.9. Aveo Oncology
    • 11.2.10. Aavogen Inc.
    • 11.2.11. Green Cross Wellbeing Corporation
    • 11.2.12. Cannabics Pharmaceuticals Inc.
    • 11.2.13. TCI Peptide Therapeutics
    • 11.2.14. Fresenius Kabi
    • 11.2.15. Tetra Bio-Pharma
    • 11.2.16. Actimed Therapeutics
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us